Anika Therapeutics Inc. (ANIK) Financials
ANIK Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 270.6 million | 58.4 million |
2023-09-30 | 328.2 million | 57.7 million |
2023-06-30 | 328.9 million | 54.9 million |
2023-03-31 | 339.1 million | 61.5 million |
ANIK Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 1.8 million | 3.8 million |
2023-09-30 | 5.7 million | 3.6 million |
2023-06-30 | -9.8 million | 4.2 million |
2023-03-31 | -5.0 million | 3.7 million |
ANIK Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | -63.0 million |
2023-09-30 | -6.6 million |
2023-06-30 | -2.7 million |
2023-03-31 | -10.4 million |
ANIK Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 72.9 million | - | 29.0 million |
2023-09-30 | 70.7 million | - | 27.3 million |
2023-06-30 | 65.1 million | - | 29.9 million |
2023-03-31 | 79.7 million | - | 30.4 million |
ANIK Shares Outstanding
ANIK Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 1.8 million | 7.6 million | 20.3 million | - |
2023-09-30 | 741000 | 7.8 million | 24.8 million | - |
2023-06-30 | 1.5 million | 8.9 million | 23.7 million | - |
2023-03-31 | 1.4 million | 8.4 million | 27.0 million | - |
ANIK Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 43.0 million | 16.6 million |
2023-09-30 | 41.5 million | 16.5 million |
2023-06-30 | 44.3 million | 15.3 million |
2023-03-31 | 37.9 million | 15.1 million |
ANIK
Price: $27.59
52 week price:
Payout Ratio Range:
Earnings Per Share: -5.64 USD
P/E Ratio: -14.19
Exchange: NMS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 53407
Ebitda: 11.5 millionMarket Capitalization: 384.0 million